CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,966,069
- in 2 filings, $18.0M under 10b5-1 plans
Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-19 | ROSSI DINO A Director | Option exercise · Stock Option (Right to Buy) | −18,950 | 0 | ||
| 2026-02-09 | ROMANO KATHRYN Chief Accounting Officer | Option exercise 10b5-1 | +12,500 | $63.55 | $794K | 31,818 |
| 2026-02-09 | ROMANO KATHRYN Chief Accounting Officer | Sale 10b5-1 | −2,000 | $270.56 | $541K | 29,818 |
| 2026-02-09 | ROMANO KATHRYN Chief Accounting Officer | Sale 10b5-1 | −5,700 | $271.66 | $1.5M | 24,118 |
| 2026-02-09 | ROMANO KATHRYN Chief Accounting Officer | Sale 10b5-1 | −2,824 | $272.51 | $770K | 21,294 |
| 2026-02-09 | ROMANO KATHRYN Chief Accounting Officer | Sale 10b5-1 | −928 | $273.71 | $254K | 20,366 |
| 2026-02-09 | ROMANO KATHRYN Chief Accounting Officer | Sale 10b5-1 | −552 | $274.64 | $152K | 19,814 |
| 2026-02-09 | ROMANO KATHRYN Chief Accounting Officer | Sale 10b5-1 | −400 | $275.68 | $110K | 19,414 |
| 2026-02-09 | ROMANO KATHRYN Chief Accounting Officer | Sale 10b5-1 | −96 | $277.88 | $27K | 19,318 |
| 2026-02-09 | ROMANO KATHRYN Chief Accounting Officer | Gift 10b5-1 | −750 | 18,568 | ||
| 2026-02-09 | ROMANO KATHRYN Chief Accounting Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,500 | 12,500 | ||
| 2025-12-05 | Krishnan Suma President, R&D | Gift 10b5-1 | −5,000 | 1,478,056 | ||
| 2025-12-05 | Krishnan Krish S President and CEO | Gift 10b5-1 | −5,000 | 1,478,056 | ||
| 2025-12-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −700 | $214.25 | $150K | 1,438,011 |
| 2025-12-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −600 | $215.49 | $129K | 1,437,411 |
| 2025-12-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −1,400 | $216.97 | $304K | 1,436,011 |
| 2025-12-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −3,593 | $218.83 | $786K | 1,432,418 |
| 2025-12-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −5,419 | $219.68 | $1.2M | 1,426,999 |
| 2025-12-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −2,627 | $220.52 | $579K | 1,424,372 |
| 2025-12-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −10,461 | $221.82 | $2.3M | 1,413,911 |
Page 9 of 35 · 689 trades